ifosfamide has been researched along with Carcinoma, Renal Cell in 11 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarcomatoid renal cell carcinoma (SRCC) is a heterogeneous disease with generally unreliable response to various therapies in clinical studies." | 1.33 | Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma. ( Bissada, NK; Chaudhary, UB; Rashid, MH; Welsh, CT, 2005) |
| "They were 26 bladder cancers and 19 renal cell cancers." | 1.30 | Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer. ( Fujita, K; Hirano, Y; Suzuki, K; Ushiyama, T, 1999) |
| "All patients had histologically proven renal cell carcinoma with widespread metastases." | 1.27 | [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs]. ( Akimoto, M; Hara, M; Hasegawa, J; Hirasawa, S; Kanamori, S; Kawamura, N; Nishimura, T; Ohhara, M; Okumura, S; Yoshida, K, 1984) |
| "In view of the divergent reports on the efficacy of ifosfamide in metastatic renal cell cancer, we tested this drug as monotherapy in nine patients on a dosage schedule of intravenous infusion of 40 mg/kg per day on days 1-5, repeated every 4 wk." | 1.27 | Ifosfamide chemotherapy of metastatic renal cell cancer. ( Baki, M; Bodrogi, I; Eckhardt, S; Sinkovics, I, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carden, MA | 1 |
| Perdahl-Wallace, E | 1 |
| Greenberg, J | 1 |
| McCarty, JM | 1 |
| Apolo, AB | 1 |
| Ostrovnaya, I | 1 |
| Halabi, S | 1 |
| Iasonos, A | 1 |
| Philips, GK | 1 |
| Rosenberg, JE | 1 |
| Riches, J | 1 |
| Small, EJ | 1 |
| Milowsky, MI | 1 |
| Bajorin, DF | 1 |
| Escudier, B | 1 |
| Droz, JP | 2 |
| Rolland, F | 1 |
| Terrier-Lacombe, MJ | 1 |
| Gravis, G | 1 |
| Beuzeboc, P | 1 |
| Chauvet, B | 1 |
| Chevreau, C | 1 |
| Eymard, JC | 1 |
| Lesimple, T | 1 |
| Merrouche, Y | 1 |
| Oudard, S | 1 |
| Priou, F | 1 |
| Guillemare, C | 1 |
| Gourgou, S | 1 |
| Culine, S | 1 |
| Rashid, MH | 1 |
| Welsh, CT | 1 |
| Bissada, NK | 1 |
| Chaudhary, UB | 1 |
| Keaney, CM | 1 |
| Springate, JE | 1 |
| Okumura, S | 1 |
| Nishimura, T | 1 |
| Yoshida, K | 1 |
| Ohhara, M | 1 |
| Hasegawa, J | 1 |
| Hirasawa, S | 1 |
| Hara, M | 1 |
| Kawamura, N | 1 |
| Kanamori, S | 1 |
| Akimoto, M | 1 |
| Hirano, Y | 1 |
| Ushiyama, T | 1 |
| Suzuki, K | 1 |
| Fujita, K | 1 |
| Bangalore, N | 1 |
| Bhargava, P | 2 |
| Hawkins, MJ | 1 |
| König, HJ | 1 |
| Gutmann, W | 1 |
| Weissmüller, J | 1 |
| Bodrogi, I | 1 |
| Baki, M | 1 |
| Sinkovics, I | 1 |
| Eckhardt, S | 1 |
| Theodore, C | 1 |
| Ghosn, M | 1 |
| Lupera, H | 1 |
| Piot, G | 1 |
| De Forges, A | 1 |
| Klink, M | 1 |
| Rouesse, J | 1 |
| Amiel, JL | 1 |
2 reviews available for ifosfamide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Cancer and the kidney.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carcinoma, Renal Cell; Comorbi | 2005 |
Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Dacarbazine; Doxorubicin; Hum | 2001 |
2 trials available for ifosfamide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carc | 2002 |
Ifosfamide, vindesine and recombinant alpha-interferon combination chemotherapy for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; | 1991 |
7 other studies available for ifosfamide and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Doxoru | 2018 |
Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.
Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; C | 2013 |
Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Female; Humans; | 2005 |
[Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Renal Cell; Cispl | 1984 |
Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drug Resistance; Drug Sc | 1999 |
Ifosfamide chemotherapy of metastatic renal cell cancer.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Ifosfamide; Infusions, Intravenous; Kidney Neopl | 1988 |
Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal | 1988 |